Vaccine Targeting Triple-Negative Breast Cancer Shows Good Response in First Clinical Trial of Patients - Good News Network
goodnewsnetwork.orgSubmitted by goodnewsnetwork7697 in health
A drug that targets the deadliest form of breast cancer has recently been found to elicit 75% immune responses with no side effects.